Mersana Therapeutics Shares Are Trading Lower. The Company Announced Initial Clinical Data From the Phase 1 Dose Escalation and Backfill Cohorts for Emiltatug Ledadotin.
Mersana Therapeutics Shares Are Trading Lower. The Company Announced Initial Clinical Data From the Phase 1 Dose Escalation and Backfill Cohorts for Emiltatug Ledadotin.
Mersana Therapeutics的股票正在交易下跌。公司宣佈了Emiltatug Ledadotin的1期劑量遞增和補充隊列的初步臨牀數據。
Mersana Therapeutics Shares Are Trading Lower. The Company Announced Initial Clinical Data From the Phase 1 Dose Escalation and Backfill Cohorts for Emiltatug Ledadotin.
Mersana Therapeutics的股價走低。該公司公佈了來自Emiltatug Ledadotin第一階段劑量遞增和回填隊列的初步臨牀數據。